Literature DB >> 219732

Modifications of the immunofluorescence assay for feline leukemia virus group-specific antigens.

E A Hoover, L E Mathes, J L Rojko, J P Schaller, R G Olsen.   

Abstract

Observations and minor modifications are presented concerning the immunofluorescence assay for feline leukemia virus (FeLV) group-specific antigens (GSA) in blood cells of cats. Data are given regarding absorption of goat FeLV GSA antiserum in vivo in cats, absorption of the antiserum in vitro with feline blood cells, and the comparative efficacy of various chemical fixatives in preservation of FeLV GSA for immunofluorescent staining. The best results were obtained with in vitro absorption of antiserum and methanol fixation of FeLV GSA in blood smears.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 219732

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN： 0002-9645            Impact factor:   1.156


  9 in total

1.  Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.

Authors:  P R Donahue; E A Hoover; G A Beltz; N Riedel; V M Hirsch; J Overbaugh; J I Mullins
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Effects of cobra venom factor treatment on latent feline leukemia virus infection.

Authors:  E H Kraut; J L Rojko; R G Olsen; D L Tuomari
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

3.  Evaluation of antiviral activity and toxicity of dextran sulfate in feline leukemia virus-infected cats.

Authors:  L E Mathes; K A Hayes; C L Swenson; P J Polas; S E Weisbrode; G J Kociba
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  Saliva as a source of feline leukemia virus antigen for diagnosis of disease.

Authors:  M G Lewis; K A Wright; L J Lafrado; P J Shanker; N E Palumbo; E D Lemoine; R G Olsen
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

5.  Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma.

Authors:  N Riedel; E A Hoover; P W Gasper; M O Nicolson; J I Mullins
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Inhibition of phorbol ester-induced neutrophil chemiluminescence by FeLV.

Authors:  C S Dezzutti; L J Lafrado; M G Lewis; R G Olsen
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.

Authors:  P J Polas; C L Swenson; R Sams; C M Cheney; K A Hayes; M J Tarr; G J Kociba; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

8.  Protection against feline leukemia by vaccination with a subunit vaccine.

Authors:  M G Lewis; L E Mathes; R G Olsen
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  S L Quackenbush; P R Donahue; G A Dean; M H Myles; C D Ackley; M D Cooper; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.